These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3526525)

  • 1. [Comments on the therapeutic approach in myeloma].
    Paule B; Médicis P; Clerc D; Ellrodt A; Bisson M; Massias P
    Rev Rhum Mal Osteoartic; 1986 Apr; 53(4):269-75. PubMed ID: 3526525
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemocytological classification, clinical staging and polychemotherapy of multiple myeloma].
    István L; Karl W; Michael H; Günter A; Kelényi G; Várbíró M; Dieter R
    Orv Hetil; 1983 Feb; 124(6):313-9. PubMed ID: 6835675
    [No Abstract]   [Full Text] [Related]  

  • 3. [Reclassification of multiple myeloma and calculation of the myelomatous mass as prognostic and therapeutic indications].
    Ricci C; Coscia GC; Uberti M; Discalzi G; Racca P
    Recenti Prog Med; 1982 Apr; 72(4):482-99. PubMed ID: 7146598
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple myeloma: a therapeutic enigma.
    Hoogstraten B
    Am J Clin Oncol; 1982 Feb; 5(1):13-9. PubMed ID: 7081135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic use of immunomodulatory drugs in the treatment of multiple myeloma.
    Raje N; Hideshima T; Anderson KC
    Expert Rev Anticancer Ther; 2006 Sep; 6(9):1239-47. PubMed ID: 17020458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteitis fibrosa cystica and secondary hyperparathyroidism in multiple myeloma.
    Bains MA; Pardoe LE; Rudin CE
    Br J Haematol; 2007 Jan; 136(2):179. PubMed ID: 17062009
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple myeloma: a tailored therapy for elderly patients.
    Pileri A; Palumbo A; Boccadoro M
    Hematol Oncol; 1993; 11 Suppl 1():67-72. PubMed ID: 8486344
    [No Abstract]   [Full Text] [Related]  

  • 8. Newer treatment options for patients in first relapse. From the Multiple Myeloma Research Foundation.
    Richardson P
    Oncology (Williston Park); 2006 May; 20(6):633-8. PubMed ID: 16773847
    [No Abstract]   [Full Text] [Related]  

  • 9. Bortezomib: a valuable new antineoplastic strategy in multiple myeloma.
    Bladé J; Cibeira MT; Rosiñol L
    Acta Oncol; 2005; 44(5):440-8. PubMed ID: 16118077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic strategies in multiple myeloma.
    Durie BG; Salmon S
    Bull Cancer; 1980; 67(4):450-7. PubMed ID: 7225602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New horizons in multiple myeloma therapy.
    Santos ES; Kharfan-Dabaja MA
    Expert Rev Anticancer Ther; 2006 Oct; 6(10):1483-501. PubMed ID: 17069532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment options for older myeloma patients. From the Multiple Myeloma Research Foundation.
    Anderson KC; Palumbo A;
    Oncology (Williston Park); 2005 Apr; 19(4):447-50. PubMed ID: 15934516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic application of sequential bone marrow biopsy in myeloma: analysis of 13 medullary biopsies].
    Paule B; Médicis P; Clerc D; Bennet P; Bisson M; Massias P
    Biomed Pharmacother; 1986; 40(7):261-4. PubMed ID: 3814757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive therapy in multiple myeloma.
    Harousseau JL
    Pathol Biol (Paris); 1999 Feb; 47(2):203-9. PubMed ID: 10192890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of thalidomide in the treatment of multiple myeloma].
    Mikala G; Jákó J; Vályi-Nagy I
    Orv Hetil; 2001 Aug; 142(33):1789-98. PubMed ID: 11573449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medical treatment of multiple myeloma].
    Astaldi G; Meardi G; Yalçin B
    Cancro; 1973; 26(5):319-37. PubMed ID: 4793834
    [No Abstract]   [Full Text] [Related]  

  • 17. Biology and therapy of multiple myeloma in 1996.
    Barlogie B; Jagannath S; Epstein J; Munshi N; Siegel D; Desikan KR; Feinman R; Hsu PL; von Bremen K; Tricot G
    Semin Hematol; 1997 Jan; 34(1 Suppl 1):67-72. PubMed ID: 9122748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of therapeutic response in multiple myeloma by means of bone marrow cytology examination.
    Rapazzini P; Bettini R; Carcano L
    Haematologica; 1984; 69(5):640-1. PubMed ID: 6437939
    [No Abstract]   [Full Text] [Related]  

  • 19. FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance.
    Yasui H; Hideshima T; Raje N; Roccaro AM; Shiraishi N; Kumar S; Hamasaki M; Ishitsuka K; Tai YT; Podar K; Catley L; Mitsiades CS; Richardson PG; Albert R; Brinkmann V; Chauhan D; Anderson KC
    Cancer Res; 2005 Aug; 65(16):7478-84. PubMed ID: 16103102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic progress--review XII. Treatment of multiple myeloma.
    Oakley JE; Franklin IM
    J Clin Hosp Pharm; 1984 Mar; 9(1):15-20. PubMed ID: 6371060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.